Compare iShares MSCI Indonesia ETF (EIDO) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs DENTSPLY SIRONA Inc — how do they compare? iShares MSCI Indonesia ETF trades at $12.21, while DENTSPLY SIRONA Inc trades at $13.85 (market cap $2.68B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while iShares MSCI Indonesia ETF pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| EIDO | XRAY | |
|---|---|---|
52-Week High | $19.22 | $16.85 |
52-Week Low | $10.80 | $9.64 |
Market Cap | — | $2.68B |
Sector | — | Health |
Enterprise Value | — | $4.83B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Indonesia ETF (EIDO) trades at $12.20, up 1.08% on the day, while technical indicators signal a bearish trend with moving averages and overall signals in sell territory. Recent news highlights Indonesia's economic initiatives, including a $15 billion AI-integrated free-meal program and central bank rate hikes to support the rupiah, which directly impacts this country-focused ETF. The fund's dividend was reported to have dropped 27% in 2025, raising questions about underlying asset performance.
The outlook for EIDO is tied to Indonesia's macroeconomic stability and government policy execution. Investment opportunity lies in exposure to Indonesia's growth initiatives, but risks include currency volatility from Bank Indonesia's defensive actions, geopolitical pressures on emerging markets, and the ETF's high-yield but potentially unstable dividend profile.
Dentsply Sirona (XRAY) trades at $12.70, down 0.63% with bearish profitability metrics including negative net income margin and ROE. The stock shows mixed technical signals with bullish moving averages but overbought RSI levels. Recent earnings have consistently missed expectations, though the company maintains a 48.93% gross margin and is expanding its US distribution network with new partnerships and AI-enabled product launches.
While analyst consensus leans Hold with a $13.33 price target, the stock faces significant fundamental challenges including declining revenue, negative earnings, and rising debt-to-asset ratios. Near-term catalysts include the Q2 2026 earnings report and continued execution of the Return-to-Growth plan, but investors should weigh the high valuation multiples against persistent profitability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
